Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Damkier

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
Clinical Epidemiology|May 5, 2022
Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled PrescriptionsKasper Bruun Kristensen, Lars Christian Lund, Peter Bjødstrup Jensen, et al.
Acta Oncologica (Stockholm, Sweden)|November 1, 2019
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based studyLindsay J Collin, Sinna P Ulrichsen, Thomas P Ahern, et al.
Pilot and Feasibility Studies|June 15, 2024
Network of doctors for multimorbidity and diabetes - the NOMAD intervention: protocol for feasibility trial of multidisciplinary team conferences for people with diabetes and multimorbidityStine Jorstad Bugge, Daniel Pilsgaard Henriksen, Per Damkier, et al.
Breast Cancer Research : BCR|December 30, 2025
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in DenmarkLindsay J Collin, Kirsten M Woolpert, Anders Kjaersgaard, et al.
Basic & Clinical Pharmacology & Toxicology|September 30, 2016
Clinical Pharmacology in Denmark in 2016 - 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical SpecialityKim Brøsen, Stig Ejdrup Andersen, Jeanett Borregaard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer PatientsThomas P Ahern, Lindsay J Collin, James W Baurley, et al.
Birth Defects Research|August 27, 2024
Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently SubstantiatedJoan D Garey, Per Damkier, Anthony R Scialli, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 8, 2025
Systematic Review and Meta-Analysis: Acetaminophen Use During Pregnancy and the Risk of Neurodevelopmental Disorders in ChildhoodAnick Bérard, Judith Cottin, Lisiane F Leal, et al.
Acta Oncologica (Stockholm, Sweden)|October 18, 2022
Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between <i>DPYD</i>-genotype variants and P-uracil concentrationsNiels Herluf Paulsen, Camilla Qvortrup, Fie Juhl Vojdeman, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Clinical Epidemiology|May 5, 2022
Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled PrescriptionsKasper Bruun Kristensen, Lars Christian Lund, Peter Bjødstrup Jensen, et al.
Acta Oncologica (Stockholm, Sweden)|November 1, 2019
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based studyLindsay J Collin, Sinna P Ulrichsen, Thomas P Ahern, et al.
Pilot and Feasibility Studies|June 15, 2024
Network of doctors for multimorbidity and diabetes - the NOMAD intervention: protocol for feasibility trial of multidisciplinary team conferences for people with diabetes and multimorbidityStine Jorstad Bugge, Daniel Pilsgaard Henriksen, Per Damkier, et al.
Breast Cancer Research : BCR|December 30, 2025
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in DenmarkLindsay J Collin, Kirsten M Woolpert, Anders Kjaersgaard, et al.
Basic & Clinical Pharmacology & Toxicology|September 30, 2016
Clinical Pharmacology in Denmark in 2016 - 40 Years with the Danish Society of Clinical Pharmacology and 20 Years as a Medical SpecialityKim Brøsen, Stig Ejdrup Andersen, Jeanett Borregaard, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer PatientsThomas P Ahern, Lindsay J Collin, James W Baurley, et al.
Birth Defects Research|August 27, 2024
Paternal Valproate Treatment and Risk of Childhood Neurodevelopmental Disorders: Precautionary Regulatory Measures Are Insufficiently SubstantiatedJoan D Garey, Per Damkier, Anthony R Scialli, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 8, 2025
Systematic Review and Meta-Analysis: Acetaminophen Use During Pregnancy and the Risk of Neurodevelopmental Disorders in ChildhoodAnick Bérard, Judith Cottin, Lisiane F Leal, et al.
Acta Oncologica (Stockholm, Sweden)|October 18, 2022
Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between <i>DPYD</i>-genotype variants and P-uracil concentrationsNiels Herluf Paulsen, Camilla Qvortrup, Fie Juhl Vojdeman, et al.
Pageof 21